Related Experiment Video

Updated: Aug 17, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.1K

Corrigendum: Predicting epidermal growth factor receptor mutation status of lung adenocarcinoma based on PET/CT

Lele Huang1,2,3, Weifang Kong4, Yongjun Luo1,2,3

  • 1Department of Nuclear Medicine, The Second Hospital and Clinical Medical School, Lanzhou University, Lanzhou, China.

Frontiers in Oncology
|February 27, 2025
PubMed

Abstract:

[This corrects the article DOI: 10.3389/fonc.2024.1458374.].

Keywords:
18F-FDG PET/CTEGFRdeep learninglung adenocarcinomamutation

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

10.8K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.5K

Related Experiment Videos

Last Updated: Aug 17, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.1K
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

10.8K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

17.5K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Articles linked to this work by shared authors, journal, and citation graph.

Biomimetic Gradient Porous Core-Shell Fibers with Enhanced Gas Sensing for CO-Temperature Dual-Mode Early Fire Warning.

Nano-micro letters·2026

Phylogeny of the subtribe Asterinae (Asteraceae: Astereae): new circumscription for Asterinae and Aster and implications for pappus evolution.

Annals of botany·2026

Individualized metabolic brain network alterations in diffuse large B-cell lymphoma: an 18F-FDG PET study.

BMC medical imaging·2026

Wearable and Highly Sensitive Sensing Fiber Enabled by Mesoporous MXene and MXene/SnSe for Ammonia Gas and Temperature Monitoring of Firefighting Clothing.

ACS sensors·2026

Comparative evaluation of nutritional risk screening tools in hospitalized children with acute gastroenteritis.

Frontiers in nutrition·2026

Performance Prediction of Antiaging Aliphatic Polyurethane Topcoat.

ACS omega·2026

Correction: Beyond inhibition: harnessing the DRD2-VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer.

Frontiers in oncology·2026

Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration framework.

Frontiers in oncology·2026

The multifaceted impact of the COVID-19 pandemic on colorectal cancer care: a systematic review of management disruptions, stage migration, and survival outcomes.

Frontiers in oncology·2026

The Cancer Epitope Database and Analysis Resource (CEDAR): current capabilities and future directions.

Frontiers in oncology·2026

Non-coding RNAs as regulators of chromosomal instability in breast cancer.

Frontiers in oncology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us